Eurofins Scientific SE
OTC:ERFSF
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| LU |
|
Eurofins Scientific SE
PAR:ERF
|
12.1B EUR |
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
213.5B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
154.8B USD |
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
81.6T KRW |
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
36.3B CHF |
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
273.1B CNY |
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
37.9B USD |
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
34.4B USD |
Loading...
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.5B USD |
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
22.9B USD |
Loading...
|
Market Distribution
| Min | -2 018.1% |
| 30th Percentile | -0.1% |
| Median | 3% |
| 70th Percentile | 6.8% |
| Max | 347.7% |
Other Profitability Ratios
Eurofins Scientific SE
Glance View
In the intricate realm of scientific services, Eurofins Scientific SE emerges as a quintessential powerhouse, orchestrating a symphony of analysis and testing across various industries. Founded in 1987, Eurofins began its journey with a focus on groundbreaking scientific methods for food and agriculture sectors. However, it rapidly diversified its expertise, leveraging its analytical prowess to expand into pharmaceuticals, environmental testing, and clinical diagnostics. The company operates through a network of laboratories scattered across the globe, each one serving as a beacon of quality and precision, embodying Eurofins' commitment to safeguarding consumer health, ensuring product safety, and supporting regulatory compliance. This robust infrastructure allows Eurofins to produce a constant stream of detailed and reliable test results, fueling its reputation and securing its place in the global market. Eurofins generates revenue primarily through its comprehensive suite of testing services, which cut across multiple sectors. Clients range from large corporations and government bodies to individual consumers who require specific tests. The company capitalizes on its broad spectrum of specialized tests, from determining the complex composition of food products to detecting elusive contaminants in pharmaceuticals and performing critical genetic screenings. This creates a diversified revenue stream that minimizes dependency on any single industry or service line. Eurofins' ability to continuously innovate and adapt its offerings ensures an ongoing inflow of clients seeking unparalleled testing accuracy and expertise. The combination of this vast service portfolio and relentless pursuit of scientific advancement underpins Eurofins' impressive financial performance and solidifies its pivotal role in the scientific services industry.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Eurofins Scientific SE is 6.5%, which is above its 3-year median of 5.4%.
Over the last 3 years, Eurofins Scientific SE’s Net Margin has decreased from 8.7% to 6.5%. During this period, it reached a low of 3.9% on Dec 31, 2023 and a high of 8.7% on Dec 1, 2022.